Literature DB >> 2838372

Hepatocellular carcinoma: diagnosis by percutaneous fine needle biopsy.

P M Bret1, M Labadie, M Bretagnolle, P Paliard, A Fond, P J Valette.   

Abstract

One hundred fifty-nine cases of hepatocellular carcinomas (HCCs) were reviewed from a series of 1060 cases of percutaneous fine needle biopsies of the liver. The biopsies were performed under ultrasonic guidance using a 22-gauge needle with a beveled tip. Specimens were obtained from the lesion and from areas of normal-appearing liver for comparison. Two sets of slides were prepared for Papanicolaou and Giemsa staining. In 147 cases (92%), the diagnosis of malignancy was established. In 134 cases (84%), the specific diagnosis of HCC was made. Fifty-four percent of the HCCs were well differentiated without cytonuclear abnormalities. In these cases, the diagnosis was made by comparison of specimens from the tumor with those obtained from the normal liver. Thirty-seven percent of the HCC were moderately differentiated with cytonuclear abnormalities. Nine percent of the HCCs were poorly differentiated, and in these cases, identification of glycogen on periodate-Schiff's procedure staining permitted differentiation from a metastatic tumor. In 9 cases, the aspirate was inadequate: there was insufficient tissue in 3 cases and the lesion was missed in the 6 other cases. In 3 cases, a biopsy of normal liver was not obtained and the diagnosis of HCC could only be suspected. Significant bleeding after biopsy occurred in 4 of 1060 cases, all with HCC.

Entities:  

Mesh:

Year:  1988        PMID: 2838372     DOI: 10.1007/BF01889073

Source DB:  PubMed          Journal:  Gastrointest Radiol        ISSN: 0364-2356


  8 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Ultrasonically guided fine-needle biopsy in focal intrahepatic lesions: six years' experience.

Authors:  P M Bret; J M Sente; M Bretagnolle; A Fond; M Labadie; P Paliard
Journal:  Can Assoc Radiol J       Date:  1986-03       Impact factor: 2.248

3.  CT-guided liver biopsies: eight years' experience. Work in progress.

Authors:  C R Martino; J R Haaga; P J Bryan; J P LiPuma; S J El Yousef; R J Alfidi
Journal:  Radiology       Date:  1984-09       Impact factor: 11.105

4.  Ultrasonically guided fine-needle biopsies in neoplastic liver disease: cytohistologic diagnoses and echo pattern of lesions.

Authors:  W B Schwerk; P Schmitz-Moormann
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

5.  Diagnosis of primary hepatic neoplasms by fine-needle aspiration cytology.

Authors:  K C Suen
Journal:  Diagn Cytopathol       Date:  1986 Apr-Jun       Impact factor: 1.582

6.  Percutaneous fine-needle aspiration biopsy of the liver. Cytodiagnosis of hepatic cancer.

Authors:  L C Tao; E E Donat; C S Ho; M J McLoughlin
Journal:  Acta Cytol       Date:  1979 Jul-Aug       Impact factor: 2.319

7.  Percutaneous fine needle biopsy (P.F.N.B.) of intra-abdominal lesions.

Authors:  P M Bret; A Fond; M Bretagnolle; F Barral; M Labadie
Journal:  Eur J Radiol       Date:  1982-11       Impact factor: 3.528

8.  Fine needle aspiration of the liver with ultrasound guidance.

Authors:  J L Nosher; J Plafker
Journal:  Radiology       Date:  1980-07       Impact factor: 11.105

  8 in total
  10 in total

Review 1.  Diagnostic biopsy for hepatocellular carcinoma in cirrhosis: useful, necessary, dangerous, or academic sport?

Authors:  J Schölmerich; D Schacherer
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Percutaneous biopsy of the liver.

Authors:  M Lüning; K Schröder; H Wolff; D Kranz; E Hoppe
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Jan-Feb       Impact factor: 2.740

3.  Focal ultrasound lesions in liver cirrhosis diagnosed as regenerating nodules by fine-needle biopsy. Follow-up of 12 cases.

Authors:  G L Rapaccini; M Pompili; E Caturelli; M Anti; A Aliotta; A Cedrone; E Amadei; A Grattagliano; M M Squillante; C Rabitti
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

4.  "Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: a single-center analysis in mainland China.

Authors:  Jian-Yong Lei; Wen-Tao Wang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

5.  Role of ultrasound guided fine needle aspiration biopsy in the diagnosis of hepatocellular carcinoma.

Authors:  G Sbolli; F Fornari; G Civardi; M Di Stasi; L Cavanna; E Buscarini; L Buscarini
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

6.  Cytological vs microhistological diagnosis of hepatocellular carcinoma: comparative accuracies in the same fine-needle biopsy specimen.

Authors:  E Caturelli; M Bisceglia; S Fusilli; M M Squillante; M Castelvetere; D A Siena
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

7.  Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs.

Authors:  Christopher G Roth; Dina Halegoua-De Marzio; Flavius F Guglielmo
Journal:  Dig Dis Sci       Date:  2018-05       Impact factor: 3.199

8.  Small (< or = 3 cm) hepatic lesions. Results of sonographically guided fine-needle biopsy in 385 patients.

Authors:  F Fornari; C Filice; G L Rapaccini; E Caturelli; L Cavanna; G Civardi; M Di Stasi; E Buscarini; L Buscarini
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

Review 9.  Circulating biomarkers for early detection of hepatocellular carcinoma.

Authors:  Boris J B Beudeker; Andre Boonstra
Journal:  Therap Adv Gastroenterol       Date:  2020-06-29       Impact factor: 4.409

Review 10.  Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review.

Authors:  Zhan-Guo Zhang; Yan Chen; Ran Ji; Ya-Jie Zhao; Jian Wang; Lily Robinson; Xiao-Ping Chen; Lei Zhang
Journal:  BMC Cancer       Date:  2018-10-29       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.